Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transposons01:24

Transposons

Transposons, or "jumping genes," are small mobile genetic elements (MGEs) that range from 700 to 40,000 base pairs in length. They are found in all organisms and can move within the same chromosome or transfer to different chromosomes. In some cases, transposons can also jump between different host DNA molecules, such as plasmids or viruses, contributing to genetic variability.Barbara McClintock first discovered these mobile genetic elements in the 1940s while studying maize genetics, and she...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
DNA-only Transposons02:57

DNA-only Transposons

DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of the functional interfaces between retroviral intasomes and the human nucleosome.

mBio·2023
Same author

[Identification of factors associated with low access to psychiatric care. Concerning 516 psychiatric assessments carried out in the framework of the local medical committee of Martinique].

L'Encephale·2022
Same author

Adcitmer<sup>®</sup> , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma.

The British journal of dermatology·2021
Same author

Mechanics and physics of a glass/particles photonic sponge.

Scientific reports·2020
Same author

An ion-pairing, reversed-phase liquid chromatography method to assess the cross-contamination of cancer chemotherapy infusions prepared in a dual-operator aseptic isolator.

Drug testing and analysis·2015
Same author

Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.

The Journal of antimicrobial chemotherapy·2015

Related Experiment Video

Updated: Jun 24, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

First Mariner Mos1 transposase inhibitors.

N Bouchet1, J Bischerour, S Germon

  • 1GICC UMR6239, Université de Tours, UFR Sciences & Techniques, Parc Grandmont, Bat L, 37200 Tours, France.

Mini Reviews in Medicinal Chemistry
|April 10, 2009
PubMed
Summary
This summary is machine-generated.

Researchers identified new chemical inhibitors for Mos1 transposition, some targeting HIV-1 integrase. These bis-(heteroaryl)maleimides show Mos1 transposase can serve as a surrogate for HIV-1 inhibitor screening.

More Related Videos

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

Related Experiment Videos

Last Updated: Jun 24, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Mos1 is a transposon, a mobile genetic element.
  • Transposons and viral integrases share similarities in their mechanisms.
  • Inhibiting these enzymes is crucial for understanding genome stability and developing antiviral therapies.

Purpose of the Study:

  • To identify novel chemical inhibitors of Mos1 transposition.
  • To explore the potential of Mos1 transposase as a surrogate for screening HIV-1 integrase inhibitors.

Main Methods:

  • Chemical synthesis of novel compounds based on a bis-(heteroaryl)maleimides scaffold.
  • Assay of compound activity against Mos1 transposition.
  • Evaluation of cross-activity with HIV-1 integrase.

Main Results:

  • Several known inhibitors of Tn5 transposase and HIV-1 integrase also inhibited Mos1 transposition.
  • Novel bis-(heteroaryl)maleimides were identified as potent Mos1 inhibitors.
  • The mechanism of action varied based on chemical substitutions on the maleimide scaffold.
  • Significant cross-activity was observed between HIV-1 integrase and Mos1 transposase inhibition.

Conclusions:

  • Mos1 transposase can be effectively inhibited by small molecules.
  • Bis-(heteroaryl)maleimides represent a promising scaffold for developing Mos1 inhibitors.
  • Mos1 transposase serves as a valuable surrogate for high-throughput screening of HIV-1 integrase inhibitors, potentially accelerating antiviral drug discovery.